Xenetic Biosciences is a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.
Personalized CAR T platform targeting cancers with a patient- and tumor-specific approach.
Our proprietary and patented technologies are being utilized to create life-changing therapies.
May 18, 2022
May 12, 2022
Stay informed about our latest news and updates